Immunetune

Immunetune is located in Leiden, Netherlands on J.H. Oortweg 19. Immunetune is rated 3 out of 5 in the category company in Netherlands. Immunetune, a new biotech company based in Leiden, is developing personalized DNA-based vaccines to treat highly mutated cancer types such as melanoma, lung-, and colon cancer. We collaborate closely with the LUMC (prof. F.A. Ossendorp) to design vaccines that train the immune system to selectively identify and eliminate tumor cells based on tumor-specific DNA mutations (neoantigens), thus yielding a type of precision medicine with an excellent safety profile.